Store-operated or capacitative calcium entry is a widespread mechanism used by electrically non-excitable cells to support sustained elevations in intracellular calcium concentration (Berridge, 1995; Lewis & Cahalan, 1995; Thomas et al. 1996; Parekh & Penner, 1997) . It is mediated by store-operated ion channels in the plasma membrane that are activated through an unknown mechanism following InsP 3 -mediated release of Ca 2+ from intracellular stores. Experimentally, any manoeuvre that causes store depletion through either active Ca 2+ release (e.g. InsP 3 , ionomycin) or passive release by impeding refilling (e.g. thapsigargin, intracellular Ca 2+ buffers) will activate these channels (Hoth & Penner, 1992; Zweifach & Lewis, 1993; Parekh & Penner, 1996; Broad et al. 1999) . The prototypical and best-characterized store-operated mechanism is the so-called 'calcium release-activated calcium' current (I CRAC ) (Hoth & Penner, 1992 Zweifach & Lewis, 1993; Lewis & Cahalan, 1995; Parekh & Penner, 1997) . This current is characterized by its high selectivity for Ca 2+ ions, an inwardly rectifying current-voltage relationship, and an extremely small singlechannel conductance in the sub-picoSiemens range (Hoth & Penner, 1993; Zweifach & Lewis, 1993) . Even whole-cell currents carried by CRAC channels are very small and specific experimental conditions need to be established in order to reliably measure I CRAC (Hoth & Penner, 1992; Parekh & Penner, 1996) . I CRAC can be carried by monovalent ions when all divalent ions are removed from the extracellular solution (Hoth & Penner, 1993; Kerschbaum & Cahalan, 1998) . Recently, several investigations have taken advantage of this feature to arrive at the first singlechannel recordings through CRAC channels (Kerschbaum & Cahalan, 1999; Braun et al. 2000; Fomina et al. 2000) . It was found that single-channel conductance of CRAC channels carrying monovalent ions is around 30-40 pS and the number of channels per cell was estimated to be around 100-400 in Jurkat lymphocytes (Kerschbaum & Cahalan, 1999) , 260-500 in RBL cells (Braun et al. 2000) and as few as 15 in resting human lymphocytes (Fomina et al. 2000) . These investigations suggest that CRAC channels can now be studied at the single-channel level.
We have recently cloned and characterized LTRPC7, a novel ion channel of the LTRPC family of ion channels (Nadler et al. 2001) . LTRPC7 is regulated by intracellular levels of Mg 2+ -complexed nucleotides and underlies a current that is strongly activated when Mg·ATP falls below 1 m (designated MagNuM for magnesium-nucleotideDissociation of the store-operated calcium current I CRAC and the Mg-nucleotide-regulated metal ion current MagNuM Washington and Children's Hospital and Regional Medical Center, Seattle, WA 98195, USA Rat basophilic leukaemia cells (RBL-2H3-M1) were used to study the characteristics of the storeoperated Ca 2+ release-activated Ca 2+ current (I CRAC ) and the magnesium-nucleotide-regulated metal cation current (MagNuM) (which is conducted by the LTRPC7 channel). Pipette solutions containing 10 m BAPTA and no added ATP induced both currents in the same cell, but the time to half-maximal activation for MagNuM was about two to three times slower than that of I CRAC . Differential suppression of I CRAC was achieved by buffering free [Ca 2+ ] i to 90 n and selective inhibition of MagNuM was accomplished by intracellular solutions containing 6 m Mg·ATP,
m free [Mg

2+
] i or 100 m GTP-g-S, allowing investigations on these currents in relative isolation. Removal of extracellular Ca 2+ and Mg 2+ caused both currents to be carried significantly by monovalent ions. In the absence or presence of free [Mg 2+ ] i , I CRAC carried by monovalent ions inactivated more rapidly and more completely than MagNuM carried by monovalent ions. Since several studies have used divalent-free solutions on either side of the membrane to study selectivity and single-channel behaviour of I CRAC , these experimental conditions would have favoured the contribution of MagNuM to monovalent conductance and call for caution in interpreting results where both I CRAC and MagNuM are activated. regulated metal current). LTRPC7 is a widely expressed ion channel that conducts Ca 2+ and Mg 2+ at negative membrane potentials. However, at potentials above +50 mV, where the driving force for divalent ions to enter the cell is small, the permeation block exerted by divalent ions is reduced and MagNuM is effectively carried by monovalent cations moving in the outward direction, a property that provides a signature for identifying LTRPC7. The permeation block of divalent ions at negative membrane potentials can be removed by omitting divalent ions from the extracellular solution, and under these conditions, MagNuM, like I CRAC , can significantly be carried by monovalent ions moving inwards. Since I CRAC and MagNuM are both present in lymphocytes and RBL cells (Nadler et al. 2001) , this provides for some ambiguity in whole-cell and single-channel studies of I CRAC , as those have been performed under experimental conditions that would also favour activation of MagNuM. We have therefore carried out experiments in RBL cells to assess the relative contributions of I CRAC and MagNuM to monovalent cation currents by selectively dissociating the currents based on their differences in activation mechanism, Mg 2+ dependence and pharmacology. We conclude that many of the reported properties ascribed to I CRAC carried by monovalent ions may require re-evaluation, since MagNuM contributes significantly to membrane currents under experimental conditions previously thought to enhance I CRAC carried by monovalent ions alone.
METHODS
For patch-clamp experiments, RBL-2H3-M1 cells (a clonal mast cell stably transfected with the muscarinic M1 receptor) grown on glass coverslips were transferred to the recording chamber and kept in a standard modified Ringer solution of the following composition (m): NaCl 145, KCl 2.8, CsCl 10, CaCl 2 10, MgCl 2 2, glucose 10, Hepes-NaOH 10, pH 7.2. In some experiments, the above solution was temporarily replaced by an otherwise identical extracellular solution in which Ca 2+ was omitted (0 Ca 2+ ) and in others both Ca 2+ and Mg 2+ were omitted and 2 m EDTA was added (divalent-free, DVF). Solution changes were performed by pressure ejection from a wide-tipped pipette. In experiments reported in Fig. 1 Patch-clamp experiments were performed in the tight-seal wholecell configuration at 24 ± 2°C. High-resolution current recordings were acquired by a computer-based patch-clamp amplifier system (EPC-9, HEKA, Lambrecht, Germany). Patch pipettes had resistances between 2 and 4 MV after filling with the standard intracellular solution. Immediately following establishment of the whole-cell configuration, voltage ramps of 50 ms duration spanning the voltage range of _100 to +100 mV were delivered from a holding potential of 0 mV at a rate of 0.5 Hz over a period of 200 to 400 s. All voltages were corrected for a liquid junction potential of 10 mV between external and internal solutions. Currents were filtered at 2.3 kHz and digitized at 100 ms intervals. Capacitive currents and series resistance were determined and corrected before each voltage ramp using the automatic capacitance compensation of the EPC-9. For analysis, the very first ramps prior to current activation were digitally filtered at 2 kHz, pooled and used for leak subtraction of all subsequent current records. The low-resolution temporal development of currents at a given potential was extracted from the leak-corrected individual ramp current records by measuring the current amplitudes at voltages of _80 and +80 mV. Effects of DVF solutions on background currents other than I CRAC and MagNuM were negligible (0.52 ± 0.13 pA pF _1 ), as determined in experiments in which neither current was allowed to activate (i.e. [Ca 2+ ] i was buffered to 90 n and 6 m Mg·ATP was added to the intracellular solution).
Ionomycin and GTP-g-S were purchased from Sigma. 2-Aminoethoxydiphenyl borate (2-APB) was kindly provided by Dr Mikoshiba (Department of Molecular Neurobiology, Tokyo University, Tokyo, Japan).
Where applicable, data are given as means ± ... with n determinations and statistical significance was assessed by Student's t test.
RESULTS
Activation kinetics of I CRAC and MagNuM
In a first series of experiments, we established conditions that would cause activation of both I CRAC and MagNuM. This was achieved by using a standard intracellular solution supplemented with 10 m BAPTA and devoid of added ATP. The extracellular solution contained 1 m Ca 2+ , which is sufficient to carry significant current through CRAC channels without unduly suppressing outward MagNuM currents. Immediately following breakin, voltage ramps from _100 to +100 mV were delivered at a rate of 0.5 Hz to continuously monitor membrane currents.
As shown in Fig. 1A , both inward and outward currents (measured at _80 and +80 mV, respectively) developed over 100-300 s. The characteristic current-voltage relationship of the conductance under these conditions is seen in Fig. 1B , which illustrates a high-resolution current record in response to a voltage ramp recorded at 300 s in a representative experiment. Under these experimental conditions, at least initially, the inward current at _80 mV is predominantly I CRAC , which activates passively as BAPTA prevents reuptake of Ca 2+ into the stores. The outward current at +80 mV is primarily MagNuM, which activates with a delay as cytosolic ATP decreases due to diffusional exchange between the cytosol and the ATP-free pipette solution. Given that there is also an inward MagNuM current, it is likely that the inward current progressively reflects a mixture of I CRAC and MagNuM components.
Kinetic analysis yields a time to half-maximal activation (t Î ) of 91 ± 8 s for I CRAC and 220 ± 6 s for MagNuM (n = 8), suggesting that the two current components are carried by distinct sets of ion channels.
Since I CRAC is activated by store depletion and MagNuM is activated by Mg·ATP depletion, we reasoned that under otherwise identical conditions, the inclusion of InsP 3 in the pipette solution, due to its active Ca 2+ release activity, would selectively accelerate store-dependent I CRAC with little or no effect on the MagNuM time course. As illustrated in Fig. 1C this is indeed the case. The half-maximal activation times in the presence of 20 m InsP 3 were 31 ± 7 s for I CRAC and 200 ± 15 s for MagNuM (n = 3). The acceleration of inward I CRAC was statistically significant (P < 0.002), whereas time courses of outward currents were not significantly different. This confirms that inward currents carried by I CRAC are store dependent, whereas outward currents are not.
Since both I CRAC and MagNuM are regulated by [Mg 2+ ] i , we carried out experiments similar to those of Fig. 1A , but omitted Mg 2+ from the pipette solutions (Fig. 1D ). This resulted in a large increase in outward current amplitude and a smaller increase in inward current, suggesting that MagNuM is more susceptible to [Mg 2+ ] i regulation than I CRAC . In terms of kinetics, t Î was 84 ± 6 s and was not significantly different from that observed in Fig. 1A , where free [Mg 2+ ] i was calculated to be 780 m. However, the time course of MagNuM was accelerated under [Mg 2+ ] ifree conditions with t Î = 151 ± 3 s (n = 5), and this shift was statistically significant (P < 1 w 10 -6 ) with respect to the time course of MagNuM shown in Fig. 1A . We attribute this acceleration to a faster decrease in cytosolic Mg·ATP levels when perfusing cells with [Mg 2+ ] i -free intracellular solutions.
Store-operated and Mg·ATP-regulated currents B, current-voltage relationship derived from a high-resolution current record in response to a voltage ramp of 50 ms duration that ranged from _100 to +100 mV, taken at 300 s from a representative cell under experimental conditions described in A. Arrows indicate _80 and +80 mV. Inward currents are predominantly I CRAC and outward currents are predominantly MagNuM. C, average inward (0) and outward (1) I CRAC and MagNuM at _80 and +80 mV, respectively (n = 3). Fig. 2A ). Under these conditions, cells developed an inward current that had the current-voltage (I-V) signature of I CRAC , whereas outward MagNuM currents were absent (Fig. 2B) . Thus, the presence of high levels of Mg·ATP selectively suppressed MagNuM and unmasked I CRAC .
In order to activate MagNuM in isolation, we omitted ATP from the pipette solution and suppressed I CRAC by clamping cytosolic free Ca 2+ to 90 n using appropriate mixtures of EGTA and Ca 2+ . As can be seen in Fig. 2C , this resulted in selective activation of predominantly outward currents with the I-V signature of MagNuM (Fig. 2D) . Note, however, that MagNuM also has an inward component, which develops in parallel with the outward component.
Based on the differential kinetics and the selective suppression of currents, the experiments so far suggest that the major portions of inward and outward currents are carried by different ion channel mechanisms, namely I CRAC and MagNuM, respectively. However, one might argue that these differences are due to changes in conductance properties of only one mechanism, namely I CRAC , and that MagNuM reflects an unusual behaviour of outward currents through CRAC channels. We have therefore performed experiments in which we first allowed MagNuM to fully activate under experimental conditions that suppress I CRAC and then applied the Ca 2+ ionophore ionomycin to actively induce store depletion. As illustrated in Fig. 2E , this resulted in a selective increase in inward current without a corresponding increase in outward current. The I-V relationships of cells prior to and following ionomycin-induced store depletion, illustrated in Fig. 2F , demonstrate in more detail the selective recruitment of an inwardly rectifying conductance with the signature of I CRAC . The additivity of I CRAC and MagNuM establishes, without reasonable doubt, that the two conductances are indeed distinct entities.
Monovalent I CRAC and MagNuM
I CRAC is a highly specific Ca 2+ current, but can support a large monovalent current when divalents are removed from the extracellular solution (Hoth & Penner, 1993; Kerschbaum & Cahalan, 1998) . Figure 3A illustrates this phenomenon under conditions where MagNuM has been suppressed by inclusion of 6 m intracellular Mg·ATP. Under these conditions I CRAC , but not MagNuM, activates due to passive depletion of Ca 2+ from intracellular stores. Upon removal of divalents, there is a transient increase in inward I CRAC as previously described (Hoth & Penner, 1993) . Note, however, that outward currents do not increase proportionally so that inward rectification of I CRAC is preserved (Fig. 3B) . Also note the rather strong inactivation of the monovalent inward current, whose underlying mechanism is at present not understood but has been proposed to be related to the presence of [Mg 2+ ] i (Kerschbaum & Cahalan, 1998) . However, as will be shown below, our data do not support this interpretation.
We have previously shown that MagNuM can also sustain a large monovalent current upon removal of all divalent ions from the extracellular solution (Nadler et al. 2001) . Figure 3C illustrates this under experimental conditions where buffering of [Ca 2+ ] i to 90 n suppresses I CRAC activation, while omission of ATP selectively leads to MagNuM activation. During application of divalent-free extracellular solution, there is a large increase in inward MagNuM current, but in contrast to the behaviour of I CRAC , there is also a significant increase in outward current even at potentials below +50 mV, which we interpret to be due to the removal of permeation block of divalent ions. As outward currents are no longer impeded by divalent ions, the MagNuM I-V relationship becomes almost linear (Fig. 3D) . Furthermore, monovalent MagNuM currents also exhibit some inactivation, most prominently of the outward current, albeit to a lesser degree than the inactivation of monovalent I CRAC .
Effects of intracellular Mg 2+ on I CRAC and MagNuM
The majority of experiments presented so far were carried out under conditions where intracellular Mg 2+ concentrations were kept in the physiological range of 0.5-0.8 m (Romani & Scarpa, 2000) . Previous studies of I CRAC have suggested that [Mg 2+ ] i contributes to inactivation and inward rectification of I CRAC through a voltage-dependent block of outward currents (Kerschbaum & Cahalan, 1998 . B, I-V relationship of I CRAC derived from high-resolution current records in response to voltage ramps of 50 ms duration that ranged from _100 mV to +100 mV. Data are taken from a representative cell under experimental conditions described in A. C, average inward (0) and outward (1) currents at _80 and +80 mV, respectively (n = 7), recorded under experimental conditions that suppress I CRAC and favour MagNuM activation. MagNuM was activated passively by omission of ATP from the pipette solution and I CRAC was suppressed by buffering [Ca 2+ ] i to 90 n using 10 m EGTA and 3.6 m CaCl 2 ([MgCl 2 ] i = 1 m, free [Mg 2+ ] i = 760 m). D, I-V relationship of MagNuM derived from highresolution current records measured with the same pulse protocol as in B. Data are taken from a representative cell under experimental conditions described in C. E, average inward (0) and outward (1) currents at _80 and +80 mV, respectively (n = 5), recorded under experimental conditions that suppress I CRAC and favour MagNuM activation. MagNuM was activated passively by omission of ATP from the pipette solution and I CRAC was suppressed by buffering [Ca 2+ ] i to 90 n using 10 m EGTA and 3.6 m CaCl 2 (free [Mg 2+ ] i = 0). I CRAC was activated by brief application (2-3 s) of 20 m ionomycin applied at the time indicated by the arrow. F, I-V relationships derived from high-resolution current records, measured as in B. Data are taken from a representative cell under experimental conditions described in E before ionomycin application (300 s, thin line) and after I CRAC had fully developed (400 s, thick line).
A further increase in monovalent MagNuM currents was achieved by omitting Mg 2+ from the intracellular solution, as illustrated in the right panel of Fig. 4C (Nadler et al. 2001) . However, we have found that GTP-g-S at 100 m can inhibit MagNuM in a Mg 2+ -and ATP-independent manner, possibly through a G protein-mediated regulation, and this allowed us to study monovalent I CRAC in isolation from MagNuM under [Mg 2+ ] i -free conditions. In this experiment, illustrated in the left panel of Fig. 4C , intracellular solutions contained 100 m Na-GTP-g-S in the absence of Mg 2+ and I CRAC was activated by 20 m InsP 3 . Under these conditions, we observed only a very small, transient increase in outward MagNuM current activation, which peaked at 0.6 pA pF _1 around 150 s into the experiment and subsequently decayed to 0.1 pA pF _1 due to GTP-g-S block. Thus the inhibition of MagNuM by GTP-g-S was essentially complete by the time DVF solution was applied, since the magnitude of the corresponding outward MagNuM current under Mg 2+ -free conditions is 3.2 pA pF _1 (right panel of Fig. 4C ).
J. Physiol. 539.2 In all panels, average inward (0) and outward (1) ] i -free conditions where ATP and MgCl 2 were omitted from the pipette solution. Therefore, both InsP 3 -mediated I CRAC and ATP-dependent MagNuM were activated. The dotted trace represents data taken from the left panel of C to illustrate the contribution of I CRAC . E, I-V relationships derived from high-resolution current records in response to a voltage ramp of 50 ms duration that ranged from _100 to +100 mV, taken at the peak of monovalent inward currents from representative cells under experimental conditions described in C. Note the linear I-V relationship of monovalent MagNuM currents and inward rectification of I CRAC .
Upon exposure to divalent-free extracellular solution, there was again a large increase in inward current, which also inactivated rather quickly. The degree of inactivation was significantly larger than the one observed with MagNuM, amounting to 73 % at the end of the DVF challenge, whereas the corresponding decrease in MagNuM was only 35 % (right panel of Fig. 4C ). Monovalent I CRAC retained considerable inward rectification, whereas the corresponding monovalent MagNuM currents were rather linear (Fig. 4E) . Finally, we performed experiments in which both I CRAC and MagNuM were allowed to activate under [Mg 2+ ] i -free conditions and perfused cells with internal solutions that included InsP 3 but were devoid of Mg 2+ and ATP (Fig. 4D) . Here, the activation of I CRAC proceeded rapidly and when the extracellular solution was changed to divalent-free there was a sudden massive increase in both inward and outward monovalent current, which was probably due to the combined contributions of I CRAC and MagNuM, followed by a slower, steady increase during the application period of divalent-free solution. We interpret this slow increase to be primarily due to MagNuM, since its activation proceeds during the divalent-free episode, as witnessed by the increased levels of outward current upon readmission of divalent-containing extracellular solution. This suggests that the contribution of MagNuM masks that of I CRAC , which is likely to be similar to the response seen in the left panel of Fig. 4C and which is superimposed here for comparison as a dotted line. Since I CRAC is subject to inactivation and MagNuM continues to increase, the latter is likely to carry the major component of monovalents under these experimental conditions.
Selectivity of I CRAC and MagNuM
We next took advantage of differences in selectivity as a further means to distinguish I CRAC and MagNuM. I CRAC is well known for the high selectivity for Ca 2+ over any other divalent ion, including Mg 2+ (Hoth & Penner, 1993 has been reported to be a selective inhibitor of storeoperated Ca 2+ entry (Ma et al. 2000) . Its inhibition of InsP 3 receptors has been interpreted in support of the conformational coupling model of I CRAC activation, where InsP 3 receptors are hypothesized to directly interact with and gate CRAC channels (Irvine, 1990; Berridge, 1995) . By the same token, the inhibitory effect of 2-APB on single channels of RBL, recorded under divalent-free conditions, has been invoked as major supporting evidence for identifying these channels as being CRAC channels (Braun et al. 2000) . We have re-investigated the effects of 2-APB under conditions where I CRAC and MagNuM are activated in the same cell. Figure 6A illustrates the InsP 3 -mediated activation of I CRAC carried by 10 m Ca 2+ . As I CRAC is almost fully activated, the delayed activation of MagNuM starts, as evidenced by the small increase in outward current. After the inward I CRAC reached its maximum, 2-APB (100 m) was applied extracellularly, and this resulted in a strong and irreversible inhibition of I CRAC . At the same time, the outward MagNuM current, which had just started to activate, was also inhibited. This inhibition, however, was not irreversible, since outward MagNuM currents recovered from 2-APB block. After significant activation of MagNuM, we re-applied 2-APB and again observed a significant, albeit not complete, inhibition of outward currents.
Thus, aside from a slightly lower efficacy in suppressing MagNuM, the major difference of 2-APB-mediated effects on I CRAC and MagNuM appears to be the degree of reversibility. Furthermore, although we are not concerned with the activation mechanism of I CRAC , this result demonstrates that 2-APB can inhibit I CRAC after it has been fully activated and it does so with a rapidity that is consistent with a direct pharmacological inhibition (Braun et al. 2000) . We observed the same type of inhibition in cells where I CRAC was activated in an InsP 3 -independent manner through passive depletion (data not shown). Furthermore, the 2-APB-induced block of I CRAC only occurred when the compound was applied extracellularly and inclusion of the same concentration of 2-APB in the pipette solution was ineffective, consistent with an interpretation that 2-APB acts as an extracellular pore blocker of CRAC channels (Braun et al. 2000) . In any event, the 2-APB-induced block of I CRAC is not selective and can therefore not be considered an identifying signature for CRAC channels. . After full activation of I CRAC , 100 m 2-APB was applied extracellularly for the time indicated by the bar and a second application was performed after MagNuM had developed. Note the differential reversibility of 2-APB-mediated inhibition of outward and inward currents. B, average inward (0) and outward (1) currents at _80 and +80 mV, respectively (n = 3), recorded under experimental conditions that suppress MagNuM and favour I CRAC activation. I CRAC was activated passively by inclusion of 10 m BAPTA in the pipette solution and MagNuM was suppressed by 6 m Mg·ATP ([MgCl 2 ] i = 1 m, free [Mg 2+ ] i = 1.1 m). After full activation of I CRAC , 10 m Gd 3+ was applied extracellularly for the time indicated by the bar. C, average inward (0) and outward (1) I CRAC and MagNuM at _80 and +80 mV, respectively (n = 3). I CRAC and MagNuM were activated passively by omission of ATP and MgCl 2 and inclusion of 10 m BAPTA in the pipette solution. After full activation of both I CRAC and MagNuM, 10 m Gd 3+ was applied extracellularly for the time indicated by the bar. Note the complete inhibition of inward current and the lack of effect on outward current.
We sought to establish a more discriminating pharmacological assay to distinguish between I CRAC and MagNuM and tested for selective Gd 3+ sensitivity of the two conductances. As illustrated in Fig. 6B , I CRAC is potently inhibited by low concentrations of Gd 3+ (10 m). However, Gd 3+ at this concentration did not significantly affect outward MagNuM currents (Fig. 6C) , while the inward current, in this case both I CRAC and MagNuM, was completely suppressed. Additionally, we confirmed that 10 m Gd 3+ could partially block inward but not outward currents in HEK-293 cells over-expressing recombinant LTRPC7 (data not shown). Thus, although Gd 3+ does not inhibit outward MagNuM currents, it does not seem to be an ideal tool to distinguish between I CRAC and MagNuM, since inward MagNuM currents, as with I CRAC , are suppressed by Gd 3+ .
DISCUSSION
The present study was designed to distinguish the Ca 2+ release-activated Ca 2+ current (I CRAC ) from the recently discovered magnesium-nucleotide-regulated metal ion current (MagNuM) (Nadler et al. 2001) . The underlying ion channels are encoded by the LTRPC7 gene, a member of TRP family of ion channel genes (Harteneck et al. 2000) . LTRPC7 is widely expressed in numerous tissues and cells (Nadler et al. 2001) . MagNuM shares some features with I CRAC , most notably a large monovalent conductance in the absence of divalent charge carriers such as Ca 2+ and Mg 2+ . Furthermore, MagNuM is activated under experimental conditions that have traditionally been used to study I CRAC . Finally, since MagNuM is also present in RBL cells and lymphocytes (Nadler et al. 2001) , the model systems used to study I CRAC , it is important to establish experimental conditions that rule out ambiguities arising from the parallel activation of I CRAC and MagNuM in these cells. This is particularly important for recently developed protocols designed to measure single-channel currents through CRAC channels (Kerschbaum & Cahalan, 1999; Braun et al. 2000; Fomina et al. 2000) , as they involve Mg·ATP and divalent-free solutions, which greatly favour the activation of MagNuM. In the following, we shall discuss the salient features of I CRAC and MagNuM.
I CRAC is a store-operated current that is activated by Ca 2+ release from intracellular stores (Hoth & Penner, 1992; Parekh & Penner, 1997) . Physiologically, this is achieved by receptor-mediated InsP 3 formation that causes store depletion. MagNuM, due to its relatively low sensitivity to Mg·ATP (millimolar), is constitutively active at low levels in resting cells, but is strongly activated by cytosolic ATP depletion below 1 m (Nadler et al. 2001) . Given the differential activation mechanisms, it is possible to isolate both conductances by appropriately composed intracellular solutions. Thus, I CRAC can be effectively suppressed by buffering [Ca 2+ ] i to resting levels around 100 n (Fasolato et al. 1993; Krause et al. 1999) et al. 2001) . However, studies on I CRAC originating from our own, as well as numerous other, laboratories have traditionally used low Mg·ATP concentrations or have completely omitted ATP from intracellular solutions. Therefore, I CRAC recordings in most of these studies have probably been contaminated to various degrees with MagNuM currents.
Kinetics of activation of I CRAC and MagNuM
Experimentally, one can trigger I CRAC activation by a variety of conditions that lead to store depletion (Hoth & Penner, 1992; Parekh & Penner, 1996) . MagNuM is activated by depletion of Mg·ATP and appears to be store independent, since active store depletion by InsP 3 does not significantly affect its activation kinetics (see Fig. 1 ). Several electrophysiological studies have used a passive store depletion protocol, where I CRAC is activated by perfusing cells with pipette solutions that contain high concentrations of Ca 2+ chelators such as EGTA and BAPTA. This results in the gradual depletion of intracellular stores due to basal leakage of Ca 2+ out of the stores into the cytosol and the inability to refill these stores, since released Ca 2+ is immediately captured by the buffers. As a result, storeoperated I CRAC is activated and reaches half-maximal amplitude at around 80 s in RBL cells (see Fig. 1 ). In these cells, ATP-free internal solutions cause activation of MagNuM with a considerably longer delay. The average half-maximal activation times of I CRAC and MagNuM differ by about 140 s (see Fig. 1 ). There is certainly some degree of variability in the kinetics of activation of both conductances, as would be expected from their activation mechanisms (store depletion and ATP depletion, respectively). It is conceivable that both currents might activate in parallel, depending on how efficiently the two activation mechanisms are engaged under various experimental conditions. Factors that may influence this include (i) the metabolic state (e.g. cells with reduced Mg·ATP levels could activate MagNuM earlier), (ii) the cell type under investigation (e.g. lymphocytes have a significantly smaller cytosol volume compared to RBL cells and may equilibrate more rapidly with the pipette solution), (iii) the series resistance of a particular patchclamped cell (e.g. higher resistances will slow diffusional exchange of cytosol and pipette solutions). One study has attempted to correlate inward and outward currents activated by store depletion and this study reported a parallel activation of inward and outward currents (Hoth, 1996) . Our present data provide no evidence for parallel activation and although, on rare occasions, we have seen similar activation time courses, in no case was there an identical correspondence; MagNuM consistently lagged behind activation of I CRAC . It is difficult to directly compare our data with those of the above investigation, since that study did not provide a quantitative assessment of average current kinetics and illustrated only anecdotal records from individual cells. Kerschbaum & Cahalan (1998) have also considered kinetic aspects of inward and outward currents through I CRAC and observed parallel activation. However, those experiments were carried out under conditions that excluded divalent ions from either side of the membrane and, as will be discussed below, are not unambiguous as they do not directly address the issue of whether the monovalent currents were carried by I CRAC and/or MagNuM.
It is important to note that previous studies have, in fact, observed kinetic differences in the activation of I CRAC carried by Ca 2+ ions and inward currents carried by monovalent ions in the absence of divalents (Kerschbaum & Cahalan, 1999; Braun et al. 2000) . Thus, Cahalan and colleagues illustrate I CRAC carried by Ca 2+ that require about 80 s for half-maximal activation, whereas monovalent currents in the same study consistently activated halfmaximally at around 200 s (Kerschbaum & Cahalan, 1999) . Both of these values are in very close correspondence to the kinetics observed in our present study. Similarly, Putney and colleagues observed characteristic kinetic delays of about 1.5-to 2-fold for monovalent currents compared to Ca 2+ currents (Braun et al. 2000) . In the light of the newly discovered MagNuM conductance, which supports large monovalent currents and matches the delayed activation kinetics of monovalent currents in the above studies, it is difficult to avoid the conclusion that at least part of the monovalent currents in those studies, if not all, reflect MagNuM rather than I CRAC .
Selectivity of I CRAC and MagNuM
MagNuM comprises inward current in the voltage range where I CRAC is carried by Ca 2+ , i.e. in the range of _100 mV to 0 mV. Thus, depending on the expression levels of a given cell type and the specific experimental conditions established by the composition of extra-and intracellular solutions, MagNuM can contribute significantly to inward currents and this contribution develops with a delay that coincides with the peak activation of I CRAC . This makes it very difficult to assess accurately the contribution of each current. The typical size of total inward current carried by divalent ions at _80 mV in RBL cells under conditions that are normally used to study I CRAC amounts to about 3 pA pF _1 . In the absence of Mg·ATP and under conditions that suppress I CRAC , MagNuM typically generates around 0.5-1 pA pF _1 , and, although these conditions do not match exactly, we can estimate that MagNuM can contribute around 15-30 % of total inward current under standard conditions used to study I CRAC .
MagNuM currents become relatively prominent above +50 mV, where they are carried by monovalent ions in the outward direction, but many investigations of I CRAC cut off data presentation obtained at these positive voltages. We are aware of one publication that specifically addresses the outward currents of RBL cells in relation to I CRAC (Hoth, 1996) . This study suggested that outward currents recorded above +50 mV were carried by monovalent ions through CRAC channels. These outward currents were only observed when the intracellular solution contained K + , but not Cs + , as the primary monovalent cation and it was concluded that CRAC channels were permeable to K + at positive voltages. This investigation was carried out with intracellular solutions containing sub-millimolar ATP levels (0.5 m), which in our hands will lead to significant activation of MagNuM. Our present study was exclusively conducted with Cs + -based intracellular solutions and this cation is clearly permeant through LTRPC7 to the same extent as K + (Nadler et al. 2001) . At present, we cannot offer an explanation for the discrepancies between these findings. However, since we can suppress all outward currents by including Mg·ATP in our intracellular solutions without suppressing I CRAC , we conclude that CRAC channels do not carry significant outward currents per se and that under our experimental conditions the predominant part of the outward currents is MagNuM.
I CRAC is normally a highly selective Ca 2+ current (Hoth & Penner, 1992 . However, removal of divalent ions from the extracellular solution leads to a characteristic loss in selectivity, so that Na + ions can permeate (Hoth & Penner, 1993; Kerschbaum & Cahalan, 1998) . This typically results in a large increase in inward current. However, this increase is only transient and monovalent currents quickly inactivate by an unknown mechanism (Hoth & Penner, 1993) . It has been proposed that this inactivation of I CRAC is regulated by intracellular Mg 2+ , since removal of [Mg 2+ ] i reduces the amount of inactivation (Kerschbaum & Cahalan, 1998) , but, as discussed below, this notion may need revision, as it is based on experiments in which MagNuM may have contributed to monovalent inward currents.
MagNuM is normally also a divalent-selective cation current, at least over the physiological voltage range of _100 to +50 mV, where it is carried by both Ca 2+ and Mg 2+ . This characteristic difference between I CRAC and MagNuM is highlighted by our experiments illustrated in Fig. 5 (Kerschbaum & Cahalan, 1998 Braun et al. 2000; Fomina et al. 2000) . Data presented in Fig. 4 An important result of the present study is that GTP-g-S can suppress MagNuM in a Mg 2+ -and ATP-independent fashion. Although GTP-g-S has also been reported to inhibit the activation of I CRAC (Fasolato et al. 1993) , this effect requires prolonged pre-exposure to GTP-g-S and delayed store depletion, whereas GTP-g-S is completely ineffective in suppressing I CRAC once it has been activated early in the experiment, e.g. when GTP-g-S is co-perfused with InsP 3 . Therefore, it is feasible to measure I CRAC in isolation under Mg 2+ -free conditions. The results presented in Fig. 4C directly demonstrate that I CRAC remains subject to inactivation even under [Mg 2+ ] i -free conditions. We can therefore assess the relative contributions of I CRAC and MagNuM to monovalent membrane currents flowing upon removal of divalent ions when both conductances are activated. The peak monovalent inward I CRAC and MagNuM currents are roughly equivalent under [Mg 2+ ] ifree conditions (Fig. 4C) . Importantly, the rapid inactivation of I CRAC is evident even under [Mg 2+ ] i -free conditions. It should be noted that the original observation of a reduction in the inactivation of monovalent currents through I CRAC in [Mg 2+ ] i -free solutions was made under experimental conditions that would inevitably reveal MagNuM as a contaminating, if not dominant, conductance. The experiment depicted in Fig. 4D reproduces this scenario and shows that, indeed, inactivation of monovalent currents is abolished in [Mg 2+ ] i -free conditions. In fact, the monovalent currents continue to increase while exposing cells to divalent-free extracellular solutions. This increase may be attributed solely to MagNuM, since InsP 3 -mediated activation of I CRAC surely was maximal at this time. Even if we assumed that at the time of switching to divalent-free solutions, I CRAC was the only pathway for monovalent ions, its contribution to inward current would have faded at the end of the divalentfree episode of the experiment due to inactivation. The dotted line in the left panel of Fig. 4C , representing the monovalent inward current through I CRAC under [Mg 2+ ] i -free conditions, illustrates the rapidly decreasing contribution of I CRAC to whole-cell monovalent currents, leaving MagNuM as the primary, if not sole, monovalent influx pathway.
Pharmacology of I CRAC and MagNuM
Investigations on I CRAC suffer from the lack of specific pharmacological tools. However, 2-APB has been shown to inhibit I CRAC (Braun et al. 2000; Bakowski et al. 2001; Prakriya & Lewis, 2001 ). This compound was originally suggested to represent a specific InsP 3 receptor antagonist (Maruyama et al. 1997) and, based on its effects on capacitative Ca 2+ entry, was subsequently invoked to support the conformational coupling model (Ma et al. 2000) , in which InsP 3 receptors are hypothesized to activate and maintain the activity of CRAC channels (Irvine, 1990; Berridge, 1995) . However, subsequent studies have recognized that 2-APB may, in fact, be a direct blocker of I CRAC and its inhibitory effect may be unrelated to its action on InsP 3 receptors (Braun et al. 2000; Bakowski et al. 2001; Prakriya & Lewis, 2001 ). Nevertheless, since 2-APB is ineffective in suppressing other channels such as L-type Ca 2+ channels and Trp-3 channels, the compound has been considered as relatively selective for I CRAC . Since 2-APB was found to inhibit both the whole-cell monovalent currents and single channels, this has been interpreted as additional evidence that they are both carried by CRAC channels (Braun et al. 2000) . In the light of the present study, this assessment may need to be revised, since 2-APB was found to also inhibit MagNuM (see Fig. 6 ) and therefore cannot selectively identify CRAC channels.
Conclusions
In the light of the properties of the newly discovered ion channel LTRPC7, which underlies the Mg-nucleotideregulated metal ion (MagNuM) current, we may need to re-evaluate some of the findings that were originally attributed to I CRAC . In particular, this applies to those studies that obtained data under experimental conditions that favour MagNuM activation, notably ATP-and Mg 2+ -free intracellular solutions (Kerschbaum & Cahalan, 1998 Braun et al. 2000; Fomina et al. 2000) . The monovalent whole-cell and single-channel currents presented in these studies may have been due to (i) I CRAC alone, (ii) MagNuM alone, or (iii) a mixture of I CRAC and MagNuM, and we will consider each of these alternatives in turn.
The above studies all assumed that monovalent currents were exclusively carried by CRAC channels. Since the intracellular solutions were ATP and [Mg 2+ ] i free, there is little doubt that MagNuM must have been contributing to monovalent currents, at least with respect to whole-cell currents, and therefore these are unlikely to represent I CRAC alone. Let us next consider that monovalent currents in the absence of any divalents on either side of the membrane are exclusively MagNuM. In this context, it is important to point out that monovalent I CRAC inactivates rapidly (Hoth & Penner, 1993; Kerschbaum & Cahalan, 1998 ) and the present study demonstrates that it does so in the absence of intracellular Mg 2+ . Since the inactivation of monovalent I CRAC proceeds faster than its activation, it seems likely that I CRAC cannot support significant monovalent current and, since MagNuM is not subject to such strong inactivation, it could provide the predominant, if not exclusive, monovalent influx pathway. In fact, most features of monovalent currents recorded in the investigations above are entirely consistent with MagNuM as the sole pathway of monovalent current under ATP-and [Mg 2+ ] i -free conditions, including kinetics, selectivity, current-voltage relationship and pharmacology.
Finally, we should consider a scenario in which both I CRAC and MagNuM contribute to monovalent currents. In order for I CRAC to do so, we would need to postulate that CRAC channels do not inactivate completely in [Mg 2+ ] ifree conditions. If this were the case, then one would expect a sequential activation of monovalent currents, first I CRAC and then followed by MagNuM. However, in previous studies, the activation kinetics of monovalent currents is consistent with MagNuM and not I CRAC . In some circumstances, Putney and colleagues have observed an 'intermediate-sized' current that was present when cells were pre-activated by thapsigargin (Braun et al. 2000) , which may be related to a similar intermediate-sized current Cahalan and colleagues have observed when recording monovalent currents in the presence of intracellular Mg 2+ (Kerschbaum & Cahalan, 1999 ) and these currents may have been due to I CRAC .
The possible contamination of I CRAC with MagNuM may also have affected the study by Parekh & Penner (1995) , where I CRAC showed little signs of inactivation in ATP-free conditions, whereas moderate to strong inactivation was observed when perfusing cells with 2 m ATP and ATPg-S, respectively. Although the general conclusions of that investigation remain valid, the overall magnitudes of the inactivation observed with these nucleotides may have been slightly overestimated, since both Mg·ATP and Mg·ATP-g-S would have also suppressed any contaminating component of MagNuM.
In summary, the present study has demonstrated the coexistence of two potential ion channel mechanisms, I CRAC and MagNuM, which both support large monovalent currents when divalent-free extracellular solutions are used. A reduction or omission of intracellular Mg 2+ significantly augments the monovalent MagNuM. Since these latter conditions have been used to study selectivity and single-channel properties of I CRAC , the results of these investigations may have to be reassessed in the light of a possible contamination with MagNuM.
